ULTRAVIST

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Israel, Lithuania, Malta, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug ULTRAVIST contains one active pharmaceutical ingredient (API):

1	Iopromide UNII 712BAC33MZ - IOPROMIDE
	The contrast-giving substance in the iopromide formulations is iopromide, a non-ionic water-soluble derivative of triiodinated isophthalic acid in which the firmly bound iodine absorbs the X-rays. Injection of iopromide opacifies those vessels or body cavities in the path of flow of the contrast agent, permitting radio-graphic visualization of the internal structures until significant dilution occurs.
	Read more about Iopromide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ULTRAVIST Solution for injection	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08AB05	Iopromide	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538912120020014, 538912120020114, 538912120020214, 538912120020314, 538912120020414, 538912120020514, 538912120020614, 538912120020714, 538919060028903, 538921030033303
CA	Health Products and Food Branch	02078600, 02078619
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28966-08-09, 29009-09-09
EE	Ravimiamet	1004803, 1004836, 1079221, 1079232, 1079243, 1079254, 1079265, 1079276, 1079287, 1079298, 1079300, 1124794, 1398753
ES	Centro de información online de medicamentos de la AEMPS	59611, 59613, 59614
FR	Base de données publique des médicaments	60385522, 62729413, 65027575, 68373358
HK	Department of Health Drug Office	43948, 43949
HR	Agencija za lijekove i medicinske proizvode	HR-H-383247003, HR-H-925013725
IL	מִשְׂרַד הַבְּרִיאוּת	7005
LT	Valstybinė vaistų kontrolės tarnyba	1007952, 1007954, 1010744, 1014624, 1014625, 1014626, 1021162, 1021163, 1021164, 1053346, 1066719, 1066720, 1066721, 1066722, 1066723, 1066724, 1066725, 1066726, 1066727, 1066728, 1066729, 1066730, 1066731, 1070871, 1070872, 1071142, 1071143, 1073644, 1073645, 1074968, 1074969, 1074970, 1074971, 1076337, 1076338, 1076339, 1076340, 1076341, 1076342, 1080786, 1080787, 1086431, 1086432, 1086433, 1086434
MT	Medicines Authority	MA1354/00401
NG	Registered Drug Product Database	04-6502
NZ	Medicines and Medical Devices Safety Authority	5122, 5123, 8930
PL	Rejestru Produktów Leczniczych	100068779, 100068785
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64051001, W64051002, W64051003, W64051004, W64051005, W64051006, W64052001, W64052002, W64052003, W64052004
SG	Health Sciences Authority	05841P, 05845P
TN	Direction de la Pharmacie et du Médicament	12853011, 12853012, 12853013, 12853014, 12853015
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546770014, 8699546770359, 8699546771936, 8699546773701, 8699546773718, 8699546773886, 8699546774142
US	FDA, National Drug Code	50419-342, 50419-344, 50419-346
ZA	Health Products Regulatory Authority	28/28/0642, 28/28/0643, 33/28/0082, 33/28/0083, 33/28/0084, 36/28/0137, 46/28/0109, 46/28/0110, V/28/173, V/28/174, V/28/175, V/28/176, V/28/177, V/28/178, V/28/179